Menu
Search
|

Menu

Close
X

Quotient Ltd QTNT.OQ (NASDAQ Stock Exchange Global Market)

8.55 USD
-0.61 (-6.66%)
As of Mar 22
chart
Previous Close 9.16
Open 9.09
Volume 74,943
3m Avg Volume 102,523
Today’s High 9.16
Today’s Low 8.50
52 Week High 11.14
52 Week Low 3.70
Shares Outstanding (mil) 65.03
Market Capitalization (mil) 556.02
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY19
21
FY18
25
FY17
22
FY16
19
EPS (USD)
FY19
-1.539
FY18
-2.036
FY17
-3.000
FY16
-1.737
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
58.10
Price to Sales (TTM)
vs sector
20.60
8.84
Price to Book (MRQ)
vs sector
22.53
4.60
Price to Cash Flow (TTM)
vs sector
--
40.07
Total Debt to Equity (MRQ)
vs sector
571.93
17.66
LT Debt to Equity (MRQ)
vs sector
568.24
13.97
Return on Investment (TTM)
vs sector
-69.16
12.12
Return on Equity (TTM)
vs sector
-694.56
13.24

EXECUTIVE LEADERSHIP

Heino von Prondzynski
Chairman of the Board, Since 2018
Salary: --
Bonus: --
Edward Farrell
President, Since 2013
Salary: $310,800.00
Bonus: $155,400.00
Jeremy Stackawitz
President, Since 2009
Salary: $318,150.00
Bonus: $421,141.00
Franz Walt
Chief Executive Officer, Director, Since 2018
Salary: --
Bonus: --
Christopher Lindop
Chief Financial Officer, Principal Financial Officer, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

route de Crassier 13
SAINT HELIER     1262

Phone: +4122.7169800

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

SPONSORED STORIES